A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102)
Clinical trial NCT00961636 · COMPLETED
Trial details
- NCT number
- NCT00961636
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-01-01
- Enrollment
- 1152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.